Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1995 Jul;41:1199–1205.

New developments in hepatitis A control.

L Yuan 1
PMCID: PMC2146181  PMID: 7647625

Abstract

An inactivated vaccine for hepatitis A was recently licensed in Canada. This is the first important development in control of the disease in 50 years. This article presents new information about the vaccine and about the groups who might benefit from it. It also provides a review of the clinical and epidemiological aspects of hepatitis A.

Full text

PDF
1199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosch F., André F. E., Delem A., D'Hondt E., Jonas S., Kunz C., Safary A., Wiedermann G. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 1992;10 (Suppl 1):S142–S145. doi: 10.1016/0264-410x(92)90570-a. [DOI] [PubMed] [Google Scholar]
  2. Bloch A. B., Stramer S. L., Smith J. D., Margolis H. S., Fields H. A., McKinley T. W., Gerba C. P., Maynard J. E., Sikes R. K. Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. Am J Public Health. 1990 Apr;80(4):428–430. doi: 10.2105/ajph.80.4.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bulkow L. R., Wainwright R. B., McMahon B. J., Middaugh J. P., Jenkerson S. A., Margolis H. S. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis. 1993 Oct;168(4):1017–1020. doi: 10.1093/infdis/168.4.1017. [DOI] [PubMed] [Google Scholar]
  4. Coutinho R. A., Albrecht-van Lent P., Lelie N., Nagelkerke N., Kuipers H., Rijsdijk T. Prevalence and incidence of hepatitis A among male homosexuals. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1743–1745. doi: 10.1136/bmj.287.6407.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dienstag J. L., Davenport F. M., McCollum R. W., Hennessy A. V., Klatskin G., Purcell R. H. Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. JAMA. 1976 Aug 2;236(5):462–464. [PubMed] [Google Scholar]
  6. Doebbeling B. N., Li N., Wenzel R. P. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health. 1993 Dec;83(12):1679–1684. doi: 10.2105/ajph.83.12.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feinstone S. M., Kapikian A. Z., Purceli R. H. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973 Dec 7;182(4116):1026–1028. doi: 10.1126/science.182.4116.1026. [DOI] [PubMed] [Google Scholar]
  8. Green M. S., Cohen D., Lerman Y., Sjogren M., Binn L. N., Zur S., Slepon R., Robin G., Hoke C., Bancroft W. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 1993 Sep;168(3):740–743. doi: 10.1093/infdis/168.3.740. [DOI] [PubMed] [Google Scholar]
  9. Gust I. D. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine. 1992;10 (Suppl 1):S56–S58. doi: 10.1016/0264-410x(92)90544-t. [DOI] [PubMed] [Google Scholar]
  10. Hadler S. C., McFarland L. Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis. 1986 Jul-Aug;8(4):548–557. doi: 10.1093/clinids/8.4.548. [DOI] [PubMed] [Google Scholar]
  11. Hollinger F. B., Khan N. C., Oefinger P. E., Yawn D. H., Schmulen A. C., Dreesman G. R., Melnick J. L. Posttransfusion hepatitis type A. JAMA. 1983 Nov 4;250(17):2313–2317. [PubMed] [Google Scholar]
  12. Holter E., Siebke J. C. Hepatitis A in young Norwegian drug addicts and prison inmates. Infection. 1988 Mar-Apr;16(2):91–94. doi: 10.1007/BF01644310. [DOI] [PubMed] [Google Scholar]
  13. Jin A., Bardsley J. Intravenous drug use and hepatitis A: an investigation of an outbreak. Can J Public Health. 1990 Jan-Feb;81(1):79–81. [PubMed] [Google Scholar]
  14. Koff R. S. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. 1992;10 (Suppl 1):S15–S17. doi: 10.1016/0264-410x(92)90533-p. [DOI] [PubMed] [Google Scholar]
  15. Lemon S. M. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985 Oct 24;313(17):1059–1067. doi: 10.1056/NEJM198510243131706. [DOI] [PubMed] [Google Scholar]
  16. Niu M. T., Polish L. B., Robertson B. H., Khanna B. K., Woodruff B. A., Shapiro C. N., Miller M. A., Smith J. D., Gedrose J. K., Alter M. J. Multistate outbreak of hepatitis A associated with frozen strawberries. J Infect Dis. 1992 Sep;166(3):518–524. doi: 10.1093/infdis/166.3.518. [DOI] [PubMed] [Google Scholar]
  17. Pavia A. T., Nielsen L., Armington L., Thurman D. J., Tierney E., Nichols C. R. A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol. 1990 Jun;131(6):1085–1093. doi: 10.1093/oxfordjournals.aje.a115601. [DOI] [PubMed] [Google Scholar]
  18. Provost P. J., Hilleman M. R. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med. 1979 Feb;160(2):213–221. doi: 10.3181/00379727-160-40422. [DOI] [PubMed] [Google Scholar]
  19. Provost P. J., Wolanski B. S., Miller W. J., Ittensohn O. L., McAleer W. J., Hilleman M. R. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). Proc Soc Exp Biol Med. 1975 Feb;148(2):532–539. doi: 10.3181/00379727-148-38578. [DOI] [PubMed] [Google Scholar]
  20. Reid J., Carter J. M. Hepatitis A--investigation and control of outbreaks in two primary schools. Public Health. 1986 Mar;100(2):69–75. doi: 10.1016/s0033-3506(86)80002-6. [DOI] [PubMed] [Google Scholar]
  21. Scheifele D. W., Bjornson G. J. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. CMAJ. 1993 Feb 15;148(4):551–555. [PMC free article] [PubMed] [Google Scholar]
  22. Shapiro C. N., Coleman P. J., McQuillan G. M., Alter M. J., Margolis H. S. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine. 1992;10 (Suppl 1):S59–S62. doi: 10.1016/0264-410x(92)90545-u. [DOI] [PubMed] [Google Scholar]
  23. Shapiro C. N., Hadler S. C. Hepatitis A and hepatitis B virus infections in day-care settings. Pediatr Ann. 1991 Aug;20(8):435–441. doi: 10.3928/0090-4481-19910801-09. [DOI] [PubMed] [Google Scholar]
  24. Shouval D., Ashur Y., Adler R., Lewis J. A., Armstrong M. E., Davide J. P., McGuire B., Kuter B., Brown L., Miller W. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine. 1993;11 (Suppl 1):S9–14. doi: 10.1016/0264-410x(93)90151-m. [DOI] [PubMed] [Google Scholar]
  25. Siegl G., Weitz M., Kronauer G. Stability of hepatitis A virus. Intervirology. 1984;22(4):218–226. doi: 10.1159/000149554. [DOI] [PubMed] [Google Scholar]
  26. Steffen R. Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations. Vaccine. 1993;11(5):518–520. doi: 10.1016/0264-410x(93)90221-i. [DOI] [PubMed] [Google Scholar]
  27. Tassopoulos N. C., Roumeliotou-Karayannis A., Sakka M., Ticehurst J., Mihalik K., Stephanou T., Purcell R. H., Papaevangelou G. An epidemic of hepatitis A in an institution for young children. Am J Epidemiol. 1987 Feb;125(2):302–307. doi: 10.1093/oxfordjournals.aje.a114530. [DOI] [PubMed] [Google Scholar]
  28. Werzberger A., Mensch B., Kuter B., Brown L., Lewis J., Sitrin R., Miller W., Shouval D., Wiens B., Calandra G. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med. 1992 Aug 13;327(7):453–457. doi: 10.1056/NEJM199208133270702. [DOI] [PubMed] [Google Scholar]
  29. Xu Z. Y., Li Z. H., Wang J. X., Xiao Z. P., Dong D. X. Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China. Vaccine. 1992;10 (Suppl 1):S67–S68. doi: 10.1016/0264-410x(92)90547-w. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES